Things Worth Wanting / HumanN
SuperBeets Heart Chews: The Story Behind the Signal
A beet, a grape seed and a molecule made from just two atoms. That is an unusually good cast for a story about how the body talks to itself, and a surprisingly interesting place to find a berry-flavored chew.
The name gets you in the door
The grape seed deserves a speaking part.
SuperBeets is a memorable name. It gives you a familiar vegetable, adds a little ambition and leaves you with a fairly clear picture of what you expect to find inside the package.
Look at HumanN’s Heart Chews formula, though, and the story gains another character: grape-seed extract. The current original Pomegranate Berry chews combine that ingredient with beetroot powder. The grape seed is central to the research HumanN cites for this particular product.
I enjoy that kind of discovery. An object presents itself simply, then rewards a closer look. Here, the closer look leads through plant chemistry, an important chapter in cardiovascular science and the practical question of how a company turns an ingredient into something a person can use conveniently.
My interest is in that whole journey. I have not taken these chews or measured a personal response to them. I am writing about the product’s design and the scientific history around it, with a clear distinction between an appealing idea and a demonstrated health outcome.
There is plenty to find interesting on those terms. You have a vegetable that is also a source of research interest, a botanical extract with a more specific composition, and a company that has built its identity around nitric oxide. The package fits in a hand. The background takes us considerably farther.
The key is to let each part of the story do its own work. A discovery explains a biological mechanism. A study investigates an intervention. A label tells us what the product contains. Put those things together carefully and the story becomes more useful, as well as more interesting.
A remarkably small messenger
One nitrogen.
One oxygen.
A great deal to say.
Nitric oxide is a small molecule with the formula NO: one nitrogen atom joined to one oxygen atom. In the cardiovascular system, it can act as a local chemical messenger. Cells in the lining of blood vessels produce it, and it can signal nearby smooth muscle to relax.
The 1998 Nobel announcement explains why that was such an important discovery. A gas made by one cell could pass through membranes and influence another cell. Researchers had uncovered an unexpected means of biological communication.
That is the part that catches my imagination. We tend to picture a message as something with a substantial container: a letter, a cable, a packet of information. Here the message can be carried by a fleeting molecule produced close to where it is needed.
The body has a talent for making our everyday categories feel incomplete. A vessel has structure, certainly, but its behavior also depends on signals. The lining participates in the action. The surrounding muscle responds.
For me, that changes the picture of circulation. It becomes a living, responsive process. The heart provides pumping action, and the vessels participate in directing the conditions under which blood moves.
The prize went jointly to Robert F. Furchgott, Louis J. Ignarro and Ferid Murad for discoveries concerning nitric oxide’s signaling role in the cardiovascular system. It recognized fundamental research. SuperBeets Heart Chews did not win a Nobel Prize, and the award is not a clinical endorsement of a supplement.
Keeping that distinction clear leaves the original discovery every bit as remarkable. It gives us the real intellectual achievement to appreciate: scientists learned that something very small and short-lived was helping coordinate the behavior of living tissue.
How the mystery came into focus
The lining was part of the answer.
A good scientific story often begins with something that does not behave as expected. The important move is to stay curious about the difference.
Furchgott’s work brought attention to the endothelium, the layer of cells lining a blood vessel. The Nobel account of his research describes how experiments in 1980 established that this lining was essential to a particular relaxation response. An unknown substance produced there was involved.
That unknown messenger became known as endothelium-derived relaxing factor, or EDRF. The name described its origin and effect before its chemical identity was understood. It was a placeholder that contained a very good question.
I like that stage of discovery. Scientists can know that something meaningful is happening while still working out what the something is. Naming the observation does not finish the investigation; it gives people a way to pursue it together.
Ignarro’s Nobel biography describes the converging work. Murad’s investigations of nitroglycerin and nitric oxide helped set the scene. In 1986, Ignarro and Furchgott independently identified the vessel-relaxing factor as nitric oxide.
The satisfaction is in that convergence. Different lines of inquiry arrive at the same small molecule, and a confusing set of observations becomes a clearer picture of how a system works.
As someone who writes about innovation and ideation, I am drawn to the way the question changes. First: why did the tissue respond differently? Then: what is the lining releasing? Finally: what else does this messenger help explain?
A consumer product encountered decades later can provide an invitation back into that history. The useful thing is to follow the invitation all the way to the discovery, where the people, experiments and reasoning become visible again.
The company behind SuperBeets
HumanN chose a molecule to build around.
On its company story page, HumanN traces its beginnings to nitric-oxide research connected with the University of Texas and places its first product in 2010. The company’s address is in Austin, and its stated focus today is cardiovascular health.
What interests me is the organizing idea. HumanN has made nitric oxide central to the way it explains its work. That gives a broad category of products a common scientific theme.
A company can begin with an ingredient, a format or an audience. Here, the story is framed around a process in the body. The commercial challenge is to make that process understandable without making it sound simpler than it is.
That is a substantial communication task. Most people have a clear picture of a beet. Far fewer have an immediate picture of endothelial signaling. The product name and format offer something familiar, while the scientific background asks the reader to learn something new.
HumanN also identifies scientific advisers in its company materials and notes that Ferid Murad joined its science team. That is part of the company’s history. Evidence for any particular formula still comes from the research relevant to that formula and its ingredients.
I find the ambition of translating research into ordinary life worth examining. The translation has several stages: choosing an ingredient, specifying its composition, deciding how it will be delivered and explaining the purpose to the person holding the package.
Each stage has its own kind of expertise. The scientist asks what can be shown. The formulator asks what can be made consistently. The designer asks what the person will understand and how the product will fit into a routine.
Heart Chews sit where those decisions meet. Their role in this collection is partly to make that meeting visible. A familiar little format can carry a surprisingly complicated history of choices.
The ingredient with another life
A winemaking byproduct gets a second assignment.
The grape-seed ingredient named on the current label is Enovita. Its supplier, Indena, describes it as an extract made from seeds originating in white-wine production. The company’s ingredient account identifies French sourcing, production at its Tours site and water as the extraction solvent.
That adds a tangible manufacturing story to the chemistry. A seed left after one process becomes the starting material for another. Someone has to recognize the useful compounds, recover the material and turn it into an ingredient with a defined profile.
I enjoy products that make me look again at the word “leftover.” It can describe material whose role in one process is finished, while saying very little about what else that material might offer.
Grape seeds contain polyphenols, a broad family of plant compounds. Proanthocyanidins are among the compounds of interest in grape-seed extracts. The specific mixture matters because “plant extract” is a category, rather than a complete chemical description.
Indena emphasizes standardization in its Enovita materials. At a practical level, standardization means setting measurable requirements for an ingredient’s composition. That helps a manufacturer work with a more consistent material than the name of the plant alone would specify.
It is an important bridge between agriculture and manufacturing. Plants are living things, grown under changing conditions. A finished supplement is expected to have an identifiable composition. The ingredient process helps connect those two realities.
This is also where the work of laboratories becomes part of the product story. Identity and composition are things to establish through appropriate methods. The attractive package is the visible end of a process that depends on much less visible measurement.
I would keep the manufacturing claim and the health claim separate. A standardized extract gives a clearer answer to what is in the ingredient. Human research addresses what happens when people take a particular preparation under particular conditions. Both questions matter, and they answer different parts of the story.
For the time capsule, that vineyard-to-ingredient journey is worth preserving in its own right. It connects a familiar plant, a source of material from another industry, extraction work and a modern consumer format.
The current original formula
Two chews, with an actual label behind the name.
This article concerns the original Pomegranate Berry SuperBeets Heart Chews. HumanN still offers that formula alongside other versions. The company’s formula explanation identifies Advanced + CoQ10 as a different product, rather than another name for these original chews.
The current product page lists the following amounts per serving and identifies two chews as its daily use instruction. These are label details, not a personal recommendation to start a supplement.
| Label item | Amount per serving |
|---|---|
| Beetroot powder | 500 mg |
| Enovita grape-seed extract | 150 mg |
| Calories | 40 |
| Total sugars | 4 g, including 4 g added sugars |
I like having the actual amounts in view. They let us talk about a particular formulation instead of allowing the product name to do all the explanatory work.
The beetroot number is the mass of beetroot powder. It is not a stated dose of nitrate. Likewise, the grape-seed amount identifies the extract in the serving; it does not make every study of every grape preparation interchangeable with this product.
HumanN’s product explanation associates the Heart Chews with support for the body’s endothelial nitric-oxide pathway through grape-seed extract. It distinguishes that approach from the dietary-nitrate pathway emphasized in its beet powder product. The brand relationship does not erase the formulation differences.
That distinction actually gives the chews a more interesting identity. A package with “beets” in the name can contain a botanical partnership in which another plant supplies the featured studied ingredient.
The format has its own logic. A ready-to-eat chew requires no measuring scoop or mixing glass. The serving is made from discrete pieces. Flavor and texture become part of the experience of using it.
I cannot give a firsthand verdict on the taste. I can appreciate the design question: how do you make a product with a scientific explanation approachable at the moment someone encounters it? A clear format is part of the answer, provided the explanation and label remain just as clear.
Follow the ingredient into the study
The method belongs in the story.
HumanN links its grape-seed discussion to a published 2013 registry study by Belcaro and colleagues. The paper examined Enovita alongside a diet-and-lifestyle management plan over four months in 119 adults with prehypertension or mild hypertension, using the terminology of that study.
There were groups receiving 150 mg or 300 mg of extract daily, and a comparison group following the management plan alone. The authors reported greater improvements in measured blood pressure in the extract groups. The supplier provided the study material.
Those details give the research a specific shape: a named extract, particular doses, a defined population and a limited observation period. It was a controlled registry study, not a randomized trial of the finished SuperBeets Heart Chews.
The findings are a reason to investigate the ingredient further. They do not establish that these chews prevent heart attacks or strokes, nor do they establish the same effect in every person who might buy them.
I think a story about science becomes more interesting when the method is allowed into the room. You can see what the researchers asked and what sort of answer the study was equipped to provide.
There is a broader research literature too. The National Center for Complementary and Integrative Health describes mixed results across grape-seed studies, with differences in preparation, dose, duration and participants. Its summary of a 2022 review found a reduction in diastolic blood pressure, but not systolic pressure, across the included trials.
That makes the wider picture more nuanced than a single number on a product page. It also reinforces why the exact preparation and question matter.
For me, respecting that nuance is part of taking an ingredient seriously. A promising finding earns attention and further investigation. A carefully bounded conclusion gives the next person something meaningful to build on.
Heart Chews are dietary supplements. They should not replace prescribed treatment. Anyone taking medication, including blood-pressure medicine, should discuss adding them with a qualified clinician or pharmacist. That conversation can account for the individual situation in a way a general product story cannot.
The design of an ordinary moment
A scientific idea still has to fit into a day.
A supplement can arrive with an extensive explanation and still meet the consumer at a very small moment: a package opened, a label read, a decision about whether it belongs in a routine.
That moment is where the chew format becomes interesting to me. The technical story has already involved ingredients and research. The user now needs understandable directions, a recognizable serving and a form that is straightforward to handle.
It is a reminder that product design includes the sequence around the object. How is it stored? What does the person need to do before using it? Can the serving be identified without improvisation? What information is available when a question comes up?
Those are ordinary questions with real consequences for usability. They are also different from the question of whether a supplement produces a health benefit. A convenient format can make a product easier to use; efficacy still needs appropriate evidence.
I appreciate the effort to make a complex subject approachable. There is room for a product to be pleasant and clearly explained. The more familiar format can lower the effort required to understand the practical steps, while the scientific explanation remains available for someone who wants to look deeper.
The challenge is especially interesting in this category because people bring hopes to health products. A good explanation should help them distinguish what the product contains, why those ingredients were chosen and what has actually been studied.
That is the kind of communication I value. It gives the reader enough information to have a better conversation, including with the professional who knows their health history. It treats curiosity as something worth supporting.
Why I chose it for the collection
Keep the path from discovery to everyday life.
My digital time capsule is interested in the journeys behind things. With SuperBeets Heart Chews, the journey passes through an unexpected cellular messenger, a company built around vascular-health research and plant ingredients prepared for a modern consumer product.
There is a useful contrast of scales here. Nitric oxide is tiny. The history of discovering what it does is large. The chew is ordinary enough to be familiar, while the background connects to experiments that changed how scientists understood blood-vessel function.
I want to preserve that connection without collapsing its stages. The discovery is one achievement. The ingredient research is another body of work. The finished product represents choices about formulation and delivery. Each deserves to be understood on its own terms.
The grape seed gives the story another dimension. A material from winemaking becomes an extracted ingredient. The process asks us to notice potential in something that might otherwise sit outside the main story of a harvest.
HumanN’s contribution is to bring its chosen ingredients and scientific theme into a recognizable product family. The original Heart Chews offer a particularly approachable example of that effort.
What makes them worth including for me is the opportunity to look behind a simple package and find people asking consequential questions: how do cells signal, what can plant compounds do, how do we study them, and how do we explain the results to someone outside the laboratory?
A time capsule should leave room for those questions. They tell us something about the era that produced the object and the kind of knowledge people wanted to bring into their everyday lives.
Useful distinctions
Questions about SuperBeets Heart Chews.
Which SuperBeets product does this article cover?
The original Pomegranate Berry SuperBeets Heart Chews from HumanN. Advanced + CoQ10 and Zero Sugar are separate formulas; their ingredients should not be assumed to match this one.
What is in the original serving?
The current product page lists 500 mg beetroot powder and 150 mg Enovita grape-seed extract per serving, with 40 calories and 4 g added sugars. HumanN identifies two chews as its daily use instruction. Check the package you have for current details.
Why does an article about SuperBeets discuss grape seeds?
Grape-seed extract is a named ingredient in the Heart Chews and the subject of the clinical study linked by HumanN. The product’s research story cannot be understood from the beetroot name alone.
Did SuperBeets win a Nobel Prize?
No. The 1998 Nobel Prize in Physiology or Medicine honored Furchgott, Ignarro and Murad for discoveries about nitric oxide signaling. The award was for fundamental science, not a supplement or its clinical performance.
Was the linked study a trial of the finished chews?
No. The 2013 paper studied Enovita grape-seed extract alongside a lifestyle plan in a controlled registry. It did not test the finished SuperBeets Heart Chews and should not be described as a randomized trial of this product.
Can the chews replace blood-pressure medication?
No. They are dietary supplements, not a replacement for prescribed treatment. Discuss their use with a clinician or pharmacist, especially if you take medication. Do not stop or change prescribed treatment on the basis of this article.
Has Rob personally tested the chews?
No. This is an editorial exploration of the company, ingredients, research history and product design. It makes no claim of personal use or a measured health response.
Read further: current Heart Chews label, HumanN’s study reference, the published registry study and NCCIH’s ingredient overview.